Alder BioPharmaceuticals's activity chart (see below) currently has 65 price targets and 54 ratings on display.
Analysts' price targets on this stock were met 7.89% of the time, taking 42.79 days on average.
Most recent stock forecast was given by from LEERINK on 17-Sep-2019. First documented stock forecast 02-Jun-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-May-2019
$20
$21
7 years 2 months 4 days ago
(17-Sep-2019)
0/2 (0%)
$1.3 (6.95%)
Buy Since 27-Jun-2018
$28
7 years 2 months 4 days ago
(17-Sep-2019)
0/2 (0%)
$17.22 (159.74%)
Hold Since 16-Sep-2019
$18
$19
7 years 2 months 5 days ago
(16-Sep-2019)
0/2 (0%)
$-0.5 (-2.70%)
Buy Since 31-Jan-2018
$20
$20
7 years 2 months 5 days ago
(16-Sep-2019)
0/3 (0%)
$1.5 (8.11%)
Buy Since 09-Nov-2016
$23
7 years 2 months 5 days ago
(16-Sep-2019)
0/5 (0%)
$3.1 (15.58%)
What is ALDR (Alder BioPharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on ALDR (Alder BioPharmaceuticals)?
Which analyst has the most public recommendations on ALDR (Alder BioPharmaceuticals)?
Which analyst is the currently most bullish on ALDR (Alder BioPharmaceuticals)?
Which analyst is the currently most reserved on ALDR (Alder BioPharmaceuticals)?